Episode Details

Back to Episodes

Peter R. Galle, MD, PhD - Expanding Options, Elevating Outcomes: The Role of First-Line Combination Therapy for Unresectable HCC

Published 9 months, 1 week ago
Description
Please visit answersincme.com/UNP860 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, an expert in hepatology discusses the latest evidence and guideline recommendations for the first-line treatment of unresectable hepatocellular carcinoma. Upon completion of this activity, participants should be better able to: Review the guideline-recommended preferred treatment options for management of unresectable HCC; and Recognize key clinical factors that should be considered when optimizing management for patients with unresectable HCC.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us